Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

4-aminopyridine inhibits KCNA5. 4 / 4

1 1 | 2

➶

dgi

No evidence text available

➶

ctd

No evidence text available

23261645

➶

reach

"We first demonstrated that I KCNQ1 was insensitive to concentrations of 4-AP known to inhibit I KCNA5 XREF_BIBR (XREF_FIG)."

20348026

➶

reach

"Current research indicates that Kv1.5, similar to Kv1.3, is inhibited by 4-AP, TEA, and some new chemicals, such as S0100176 (from Sanofi-Aventis) or diphenyl phosphine oxide-1 (DPO-1) 2."

21423392

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...